Credit-card giant Capital One Financial Services Inc. says consumers are hanging in there as the U.S. braces for the fallout ...

Enphase Energy's top and bottom lines missed analyst projections. The energy technology company posted earnings of 22 cents a share on revenue of $356 million, compared with analyst views for earnings ...

The U.S. stock market performs far better at night than during the day. The performance of this so-called overnight effect ...

Chinese advertisers have been a major source of growth for Meta — but analysts say a sizable amount of revenue is at risk ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Tesla post-earnings calls start with questions from retail investors, which are usually very sympathetic to the company and its milestones. The part of the call with Wall Street analysts just got ...

Tesla's post-earnings call just ended, and the stock is up nearly 5% in the after-hours session. Tesla missed expectations by a mile, but that didn't matter for the stock, which is rallying 5%. Invest ...

Tesla is expected to post a drop in earnings per share for the latest quarter, along with essentially flat revenue. Analysts model 41 cents in adjusted EPS for the first quarter, down from 45 cents a ...

West Fraser Timber reported an increase in sales and earnings per share on a sequential basis as the company continued to benefit from the more balanced supply and demand fundamentals seen in recent ...

Chobani said it will build a $1.2 billion dairy processing plant in Rome, N.Y. The company said Tuesday it expects the 1.4 million square-foot facility to create over 1,000 full-time jobs. The plant ...

Musk reiterated his prediction that there will be "millions of fully autonomous Teslas" on roads by the middle of next year, with the possible exception of instances of inclement weather. You can be a ...

Health and Human Services Secretary Robert F. Kennedy Jr. and the Food and Drug Administration announced a plan to phase out ...